- World rank, all time
- #39,213 of 42,892
- Rank in United Kingdom
- #2,102 of 2,253
- Research works
- 151 ◆ 2% vs 2013–17
- Citations
- 1.3k 8.4 per fractional work
- Top-10% rate
- 7.0% record average 16.5%
- Open access
- 43% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 10.0×. Every wedge is a field page.
Who are the top researchers at BresMed?
Ranked on the composite score, Anthony J. Hatswell and Dawn Lee lead among researchers whose main affiliation is BresMed.
- 1 Anthony J. Hatswell United Kingdom · #1,120,574 worldwide 14 citations · 17 works
- 2 Dawn Lee United Kingdom · #1,390,993 worldwide 16 citations · 19 works
Which keywords describe research at BresMed?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Pharmaceutical Industry, Clinical Trials, Drug Development Costs, Generic Drugs and Inflammation.
- Targeted Therapy
- Myelofibrosis
- JAK2 Mutation
- Immunogenicity
- Biosimilars
- PD-1 and PD-L1
- Pediatric Pharmacokinetics
- Drug Resistance
- Antiepileptic Drugs
- Rituximab
- Hypertension
- Lymphoma
- Tumor Microenvironment
- Diagnosis
- Financial Toxicity
- Immunotherapy
- Drug Development Costs
- Pharmaceutical Industry
- Inflammation
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Clinical Trials
- Epidemiology
- Generic Drugs
- Cost of Care
- Genetics
- Classification
- Chemotherapy
- Cardiovascular Risk
- Prognostic Factors
- Minimal Residual Disease
- Medication Adherence
- Off-Label Drug Use
- Immune Checkpoint Blockade
- Prognostic Scoring System
- Diagnosis Criteria
- International Myeloma Working Group
- Monoclonal Antibodies
- PET Imaging
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life25▲ 12×8 topics
- Cost-effectiveness Analysis23▲ 195×1 topic
- Health Utility Measures23▲ 195×1 topic
- Inflammation11▲ 3.0×17 topics
- Clinical Trials9▲ 9.6×11 topics
- Pharmaceutical Industry9▲ 149×2 topics
- Epidemiology9▲ 1.41×24 topics
- Drug Development Costs8▲ 204×1 topic
- Generic Drugs8▲ 204×1 topic
- Immunotherapy6▲ 5.7×7 topics
- Cost of Care5▲ 192×1 topic
- Financial Toxicity5▲ 192×1 topic
- Genetics5▲ 4.3×8 topics
- Diagnosis5▲ 3.0×13 topics
- Classification4▲ 8.1×2 topics
- Tumor Microenvironment4▲ 8.3×5 topics
- Chemotherapy4▲ 3.9×11 topics
- Lymphoma4▲ 18×2 topics
- Cardiovascular Risk4▲ 7.2×6 topics
- Hypertension3▲ 6.3×3 topics
- Prognostic Factors3▲ 5.0×8 topics
- Rituximab3▲ 14×3 topics
- Minimal Residual Disease3▲ 33×2 topics
- Antiepileptic Drugs3▲ 21×2 topics
- Medication Adherence3▲ 37×2 topics
- Drug Resistance3▲ 6.4×2 topics
- Off-Label Drug Use3▲ 55×1 topic
- Pediatric Pharmacokinetics3▲ 55×1 topic
- Immune Checkpoint Blockade3▲ 34×1 topic
- PD-1 and PD-L13▲ 34×1 topic
- Prognostic Scoring System3▲ 54×2 topics
- Biosimilars3▲ 122×1 topic
- Diagnosis Criteria3▲ 61×1 topic
- Immunogenicity3▲ 36×1 topic
- International Myeloma Working Group3▲ 61×1 topic
- JAK2 Mutation3▲ 88×1 topic
- Monoclonal Antibodies3▲ 13×2 topics
- Myelofibrosis3▲ 88×1 topic
- PET Imaging3▲ 8.4×4 topics
- Targeted Therapy3▲ 8.3×4 topics
Which research topics does BresMed publish most on?
By volume in 2022–2025: Muscle Physiology and Disorders, Innovation Policy and R&D, Health Systems, Economic Evaluations, Quality of Life and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Muscle Physiology and Disorders Molecular Biology 2 works
- 2 Innovation Policy and R&D Economics and Econometrics 1 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 5 Mast cells and histamine Immunology 1 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 7 Multiple Myeloma Research and Treatments Hematology 1 works
- 8 Viral-associated cancers and disorders Oncology 0 works
- 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 10 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has BresMed's research output changed?
Output in 2018–2022 was 2% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sheffield
- University of Sheffield
- Sheffield Hallam University
- Royal Hallamshire Hospital
- Northern General Hospital
- Sheffield Teaching Hospitals NHS Foundation Trust
- Sheffield Children's Hospital
- Sheffield City Council
- Jessop Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.